MyOTCStore.com: Your Guide to Pharmaceuticals - Page 2

Prescriber Education Resources: Guides for Doctors on Generics

• 9 Comments
• Feb, 18 2026

Doctors prescribe generics for 90% of U.S. prescriptions, yet many still have doubts. Learn how FDA guides, real data, and practical tools help clinicians confidently recommend generics and improve patient outcomes.

Pain Medications: Opioids vs. Non-Opioids - What’s Really Safer?

• 10 Comments
• Feb, 15 2026

Opioids aren't more effective than non-opioid pain meds - but they come with far greater risks. Learn why guidelines now recommend non-opioid options first for chronic and acute pain.

Safe Use of Topical Medications and Creams in Children: A Practical Guide for Parents

• 11 Comments
• Feb, 11 2026

Topical medications for children can be dangerous if misused. Learn which ingredients to avoid, how much to apply, and safer alternatives for rashes, eczema, and teething pain in infants and toddlers.

Patent Term Restoration (PTE): How It Extends Drug Patent Life

• 15 Comments
• Feb, 8 2026

Patent Term Restoration (PTE) lets drug makers recover time lost during FDA approval, extending market exclusivity up to five years. Learn how it works, who qualifies, and why it's controversial.

Bioequivalence Studies: What the FDA Requires Manufacturers to Prove

• 14 Comments
• Feb, 7 2026

The FDA requires generic drug manufacturers to prove bioequivalence through rigorous pharmacokinetic studies, ensuring their products match the brand-name drug in absorption and effectiveness. This process is critical for patient safety and drug affordability.

FDA's New Patient Medication Information Rules: What You Need to Know

• 10 Comments
• Feb, 6 2026

The FDA's proposed Patient Medication Information rule aims to standardize prescription drug labels for all outpatient medications. This change could reduce medication errors that cause over a million injuries yearly. Learn how the new system works and what it means for patients and pharmacies.

Retinal Vein Occlusion: Understanding Risk Factors and Treatment Injections

• 11 Comments
• Feb, 4 2026

Retinal vein occlusion (RVO) causes sudden vision loss due to blocked retinal veins. This article explains common risk factors like hypertension and diabetes, how anti-VEGF injections treat macular edema, and real-world treatment challenges. Learn why early detection matters and what to expect from modern therapies.

Opioid Monitoring During Treatment: How Urine Drug Screens and Risk Stratification Improve Safety

Urine drug screens and risk stratification are essential tools in opioid treatment to detect adherence, prevent overdose, and catch hidden drug use. Learn how tests work, their limitations, and how to ensure accurate results.

Immunocompromised Patients and Medication Reactions: What You Need to Know About Special Risks

• 8 Comments
• Feb, 1 2026

Immunocompromised patients face higher risks of severe infections and atypical symptoms when taking immunosuppressants. Learn how different drugs affect immunity, what signs to watch for, and how to stay safe while managing chronic illness.

Boxed Warning Changes: How FDA Drug Safety Labels Evolve Over Time

• 10 Comments
• Jan, 31 2026

Boxed warnings are the FDA's strongest safety alerts for prescription drugs, signaling life-threatening risks. Learn how these warnings are added, updated, and tracked over time - and why delays in updates can put patients at risk.